Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics, Efficacy, and Safety of Antibiotics in the Oldest-Old Population
jRCT1041260081Recruiting
- Sponsor
- N/S
- Start
- Jul 2026
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of piperacillin, tazobactam, ceftriaxone, ampicillin and sulbactam in Infectious disease (3 arms), sponsored by N/S. Primary endpoint: Pharmacokinetics of tazobactam/piperacillin, ceftriaxone or ampicillin/sulbactam in plasma. Started Jul 2026; status: recruiting.
02
Drugs
03
Conditions
Infectious disease
Beyond the preview
Go deeper on jRCT1041260081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041260081.